TXG - +33% Upside with 1:2 RRBreakout of key resistance level.
Momentum building.
Trend reversal that is on the verge of a pop off.
TXG trade ideas
TGX.NYSE 10X Genomics Trend Cloud Study Potential 100% Upside.10X Genomics Trend Cloud Study shows a Potential 100% Upside.
This Ticker is way oversold and a Double Bottom is Seen.
Very Risky and Speculative. I'm Nibbling a few $100.
As always, please get a few outside Expert's Advice before making Trade or Investment Decisions.
Should you appreciate my Chart Studies, Smash That Rocket Boost Button. It's Just a Click away.
Regards Graham.
7/10/24 - $txg - Small swing, mid $15s7/10/24 :: VROCKSTAR :: NASDAQ:TXG
Small swing, mid $15s
- Illumina buying Fluent matters
- Have been skeptical of financials on NASDAQ:TXG for some time (and it's a Cathie owned name which has kept me even more discerning)
- Still have a tough time justifying valuation mainly bc cash burner and product seems to be inferior to other names + margin dilution from this competition
- ASSUMING (let's not make an A** friend) this R&D is still somewhat useful, this stock would be a pretty clear buy near the $15 level
- WE REMAIN in a risk off environment for non-mega caps (I've written extensively about this) and essentially you don't get paid to neck out unless YOU KNOW something better than the market or the cash-return valuation is super rich and it's sucking mainly b/c it's a small size company (factor issue)
- SO THAT SAID, this co is NOT in my sphere of competence so i'm only swinging a small trade here and will monitor it
- I'd LOVE thoughts from anyone w a more nuanced POV
For reference i'm posting my private comment (prior to when i started airing out my thought laundry) for a take-look at sub $20.
V
--
5/6/24 - vrockstar - looking again here and just can't come around to owning this on the surface financials. while there's a small bend in trend on the sales level vs. last year, they're still burning cash (albeit not as much), and a lot of that "help" on the FCF line is stock comp (which in a lower for longer stock is not really cash b/c these sales will dump stock lower - so it's a matter of reclassifying it in terms of stock performance). Anyway, for MSD growth "then" inflecting to 15% in '25 - and not profitable - would probably require a market mutliple of AT MOST 4x today - and we're in the high 4's even at stock lows here. I think 2.5x is appropriate to take another look, but willing to entertain if/as we get to 3x which on $670 - would be a pretty hefty discount here - let's just say 30% starting stakes which would take us easily below 20. That's my "look again trigger".
TXG possible reversalOversold on the daily, Filled Gap from Nov 2023, Risk is todays low 35.42. Rsi curl .
PT is open, had previous support at 40.40 which would be 1st resistance , SMA or fib levels also
TXG approaching support zonesAnticipating support in these zones wont hurt. Keeping strict stop loss and following long trade has a higher probability to win
Best stock to buy nowBest stock to buy now - 23.05.2023
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
TXG Healthcare name we are shortA small position is suggested due to our stance on Healthcare being bullish and also the R isn't quite at 2.00 as of yet.
10X Genomics, Inc - Bullish divergenceOn the above 6-day chart price action has corrected 75% since the sell signal back in November 2020. A number of reasons now exist to be long, including:
1) Double ‘incredible buy’ signals. Awesome.
2) Price action and RSI resistance breakouts.
3) Price action is arrested by past support / resistance.
4) Regular bullish divergence following capitulation. Lovely.
Is it possible price action falls further? Sure.
Is it probable? No.
Ww
Type: trade
Risk: 6% of portfolio
Timeframe: Rather not say
Return: 100% for starters
14/4/2022 NASDAQ (TXG)Short (Entry Price) within the sell zone area and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price.
Entry Price: $68.33 / $70.99
Target Price: $65.60 / $69.04
Stop Loss: $72.94
10x Genomics (NASDAQ: $TXG) Looks Ready For Growth! 🍄10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
TXG for an oversold bounceLong TXG 2,000 shares and 51 $110 Feb 18th calls. There has been some interesting call option activity on TXG as of last week 1/25/2022 someone purchased 600 Feb 18, 2022 $110 calls and 600 Feb 18, 2022 $120 calls and paid approximately $400k for these call options for a stock with little option activity I find this intriguing. I believe the EW correction is complete and this should bounce to the $130+ range swiftly. It's a very volatile stock. 89% institutional support and recent government contracts over $2m in Q4 www.quiverquant.com
$TXG Double Bottom Setup$TXG working on a well defined double bottom base.
2 things grabbed my attention that made me pause while flipping through charts:
* Vol dry up while rounding up that 2nd bottom
* Pretty much pocket pivot after pocket pivot through out the rally from 2nd bottom(aggressive buying)
$TXG Breakout?A lot of accumulation volume and we are at historic resistance so a breakout is plausible here. Good Luck!
big resistance area inbound.. time to unload shares if long ?hmmthis ticker has been range bound for around 10 months! will most likely get rejected off this big resistance area at 200.. And even if it breaks out the average volume is under 1 million... so i doubt the breakout would hold for long! traders usually look for higher volume stocks 2-5 million+ or more on average. always keep the volume of the stock in mind when trading, above average volume is always a plus. if you enjoyed my idea dont forget to like and follow <3
TXG 🌦Although I didn't identify an LDC on the 5 min, I resorted to using XLV to time an entry. Never rely solely on one chart to make projections get a feel of where the overall market is heading.
Wave Count.The count shows the price is testing an important fib level of 0.382 as the price is approaching its wave 4. Area $144 / $147 to be double-checked for a possible rebound.
